Skip to content

Efficacy of Individualized Homoeopathic Medicines in Acne Vulgaris and Its Psychological Impact Assessed Using Quality of Life Questionnaire in the Age Group of 10 18 Years: A Randomized Uncontrolled Clinical Trial

Randomised Uncontrolled Clinical Trials for the Efficacy of Individualized Homoeopathic Medicines in Acne Vulgaris - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107733
Enrollment
47
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Individualized Homoeopathic Treatment for Acne Vulgaris: The intervention in this study consists of individualized homoeopathic treatment aimed at addressing both the clinical and psych

Sponsors

Sonajirao kshirsagar homoeopathic medical college Beed
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals of both sexes between the age group of 10 18 years will be considered. Only patients diagnosed with acne vulgaris will be included in the study Scale for assessment is Acne-QoL Acne-specific quality of life questionnaire Patients and their parents or guardians must provide informed consent to participate in the study Patients with regular follow-up visits for the duration of the study

Exclusion criteria

Exclusion criteria: Patients with acne fulminans, acne rosacea, or other severe dermatological conditions Patients with significant systemic or endocrine disorders, such as polycystic ovary syndrome (PCOS) or active infections that could influence the study outcome

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be to assess the clinical efficacy of individualized homoeopathic medicines in the management of acne vulgaris among the pediatric age group (10 18 years). This will be evaluated by comparing the pre-treatment and post-treatment clinical presentation of acne lesions, including reduction in number, severity, and type of lesions such as comedones, papules, pustules, and nodules.Timepoint: Outcome measures will be assessed at predefined time intervals during the study period as follows: Baseline (Week 0) Prior to initiation of intervention Week 4 (1 Month) First follow-up assessment Week 8 (2 Months) Second follow-up assessment

Secondary

MeasureTime frame
The secondary outcome of the study will be to evaluate the improvement in the quality of life (QoL) of patients suffering from acne vulgaris. This will be assessed using a validated Acne-specific Quality of Life Questionnaire (Acne-QoL) by comparing scores before & after the intervention.Timepoint: Secondary Outcome Time Points of Assessment The secondary outcomes will be assessed at the following predefined time points: Baseline (Week 0) Prior to initiation of intervention Week 4 First follow-up assessment Week 8 Second follow-up assessment

Countries

India

Contacts

Public ContactDr. Ashwini Ramesh Poskar

Vidyanagar Road, Beed Maharashtra 431122 India

draage.md@gmail.com9422744892

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026